 | This redirect does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Header
edit- The following discussion is closed. Please do not modify it. Subsequent comments should be made in a new section.
The result was merge into 5-HT3 receptor. -- Boghog2 21:08, 18 June 2007 (UTC)
Proposed disambiguation
editAll the info in this article is on the receptor. Instead of creating a disambiguation page, I'd suggest merging all this info into 5-HT3 receptor and posting a {{redirect}} at the top directing readers to serotonin: 5-HT3 redirects here: for the neurotransmitter, see serotonin. Any other thoughts? delldot | talk 02:54, 12 February 2007 (UTC)
- I believe the mechanism is different for this receptor than for the others, so it might be easier to maintain if we didn't merge. --Arcadian 06:20, 14 February 2007 (UTC)
- Unless I am mistaken, 5-HT refers to the serotonin ligand and 5-HT3 refers only to the receptor and not the ligand (the subscript 3 in 5-HT3 denotes a receptor subtype and not a ligand subtype). Hence if 5-HT3 and 5-HT3 receptor were merged, there would be no need to have a disambiguation page nor a redirect. Therefore I second the motion for merger, however without a redirect. Boghog2 20:05, 17 June 2007 (UTC)
- I could support that. --Arcadian 22:21, 17 June 2007 (UTC)
- Unless I am mistaken, 5-HT refers to the serotonin ligand and 5-HT3 refers only to the receptor and not the ligand (the subscript 3 in 5-HT3 denotes a receptor subtype and not a ligand subtype). Hence if 5-HT3 and 5-HT3 receptor were merged, there would be no need to have a disambiguation page nor a redirect. Therefore I second the motion for merger, however without a redirect. Boghog2 20:05, 17 June 2007 (UTC)
The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.